Research of 20,22-desmolase Deficiency has been linked to Adrenal Hyperplasia, Congenital Adrenal Hyperplasia, Hyperplasia, Adrenal Gland Hypofunction, Chronic Active Hepatitis. The study of 20,22-desmolase Deficiency has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to 20,22-desmolase Deficiency include Transport, Pathogenesis, Cholesterol Transport, Localization, System Development. These pathways complement our catalog of research reagents for the study of 20,22-desmolase Deficiency including antibodies and ELISA kits against CORTICOTROPIN-RELEASING HORMONE, CHOLESTEROL DESMOLASE, AR, CYP11A1, CYP19A1.
20,22-desmolase Deficiency Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on 20,22-desmolase Deficiency below!
For more information on how to use Laverne, please read the How to Guide.
We have 996 products for the study of 20,22-desmolase Deficiency that can be applied to Western Blot, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.